Biology and Molecular Pathogenesis of Mature T-Cell Lymphomas.

Cold Spring Harbor Perspectives in Medicine
José R Cortés, Teresa Palomero

Abstract

Peripheral T-cell lymphomas (PTCLs) constitute a highly heterogeneous group of hematological diseases with complex clinical and molecular features consistent with the diversity of the T-cell type from which they originate. In the past several years, the systematic implementation of high-throughput genomic technologies for the analysis of T-cell malignancies has supported an exponential progress in our understanding of the genetic drivers of oncogenesis and unraveled the molecular complexity of these diseases. Recent findings have helped redefine the classification of T-cell malignancies and provided novel biomarkers to improve diagnosis accuracy and analyze the response to therapy. In addition, multiple novel targeted therapies including small-molecule inhibitors, antibody-based approaches, and immunotherapy have shown promising results in early clinical analysis and have the potential to completely change the way T-cell malignancies have been treated traditionally.

References

Feb 12, 2000·Molecular and Cellular Biology·X R Bustelo
Jul 5, 2003·Blood·Robert GniadeckiHans Christian Wulf
May 17, 2005·Nature Medicine·Roberto ChiarleGiorgio Inghirami
May 23, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen M AnsellPeter Borchmann
Jun 9, 2007·British Journal of Haematology·Yuanping ZhouMing-Qing Du
Jun 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elise A OlsenMadeleine Duvic
Nov 29, 2007·Journal of Clinical Pathology·E Matutes
Dec 17, 2008·Hematology·Kerry J Savage
May 29, 2009·The New England Journal of Medicine·François DelhommeauOlivier A Bernard
Oct 1, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Madeleine DuvicYoun H Kim
Feb 24, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kazuhito YamamotoRyuzo Ueda
Jun 30, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ali BazarbachiOlivier Hermine
Sep 9, 2010·Proceedings of the National Academy of Sciences of the United States of America·Joanna PancewiczChristophe Nicot
Jan 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Owen A O'ConnorSteven Horwitz
Jan 29, 2011·Blood·Dennis D WeisenburgerUNKNOWN International Peripheral T-cell Lymphoma Project
Mar 1, 2011·Blood·Richard L PiekarzSusan E Bates
Jun 16, 2011·Blood·Ali BazarbachiOlivier Hermine
Jun 28, 2011·Advances in Cancer Research·Charles R M Bangham, Frédéric Toulza
Sep 3, 2011·Cell Stem Cell·Luisa CimminoIannis Aifantis
Sep 17, 2011·The American Journal of Surgical Pathology·John K C ChanWai-Kong Chan
Nov 19, 2011·American Journal of Clinical Pathology·Alexandra C HristovMichael J Borowitz
Jan 6, 2012·The New England Journal of Medicine·Lucile CouronnéOlivier A Bernard
Jan 25, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bertrand CoiffierSteven Horwitz
Feb 9, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Takashi IshidaRyuzo Ueda
Mar 24, 2012·Critical Reviews in Oncology/hematology·Andrés J M FerreriKerry J Savage
May 23, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Barbara ProAndrei Shustov
Jun 19, 2012·Cancer Discovery·Ghee Chong KooSoon Thye Lim
Jul 10, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Seok Jin KimUNKNOWN Consortium for Improving Survival of Lymphoma (CISL) investigators
Jul 14, 2012·Critical Reviews in Oncology/hematology·Andrés J M FerreriKerry J Savage
Aug 8, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Massimo FedericoJulie M Vose
Dec 10, 2013·Seminars in Cancer Biology·Philippe Gaulard, Laurence de Leval
Dec 11, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roberto N MirandaL Jeffrey Medeiros
Jan 15, 2014·Nature Genetics·Mamiko Sakata-YanagimotoShigeru Chiba
Jan 29, 2014·Seminars in Hematology·Ritsuro Suzuki
Feb 5, 2014·Journal of the National Cancer Institute·Carlo Gambacorti PasseriniRocco Piazza

❮ Previous
Next ❯

Citations

Feb 2, 2021·Frontiers in Cell and Developmental Biology·Nikolas James TsiouplisAgeliki Tsagaratou
Jul 3, 2021·Life·Srikanth Umakanthan, Maryann M Bukelo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.